Strain Information | |
---|---|
Image | |
BRC No. | RBRC05036 |
Type | Gene Trap![]() |
Species | Mus musculus |
Strain name | B6C3-Gt(venusTrap_fJAV0028-E)4004-1014 |
Former Common name | |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | Developed by Takashi Hiiragi, Max-Plank Institute for Molecular Biomedicine. |
Strain description | Fluorescence-based promoter gene-trap for reverse orientation of Zbtb11 (Chr16: 56,003,722-56,003,764) |
Colony maintenance | |
References | Venus trap in the mouse embryo reveals distinct molecular dynamics underlying specification of first embryonic lineages. Dietrich J E, Panavaite L, Gunther S, Wennekamp S, Groner A C, Pigge A, Salvenmoser S, Trono D, Hufnagel L, Hiiragi T EMBO Rep., 16(8):1005-1021(2015). 26142281 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
IRES | internal ribosomal entry site (EMCV) | 16 | |||||
Venus | Yellow Fluorescent Protein (Aequorea victoria) | 16 | Venus | ||||
Zbtb11 MGI:2443876 | zinc finger and BTB domain containing 11 | 16 | Zbtb11 |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Lentivirus self-inactivating backbone (sinLV), lentivirus self-inactivating long terminal repeat (sinLTR), adenovirus type2 major late transcript intron 1/exon 2 splice acceptor, EMCV (Encephalomyocarditis virus) internal ribosomal entry site (IRES), jellyfish Venus (amino-acid substitution variant of GFP), SV 40 nuclear localaization signal (chemically-synthesized nucleotide), Woodchuck hepatitis post-transcriptional regulatory element; Central poly-purine tract (PPT), Woodchuck hepatitis post-transcriptional regulatory element; Rev-responsive element (RRE) |
Research application | Fluorescent Proteins/lacZ System covid19_infection |
Specific Term and Conditions | a) A recipient shall acquire a prior written consent from the Depositor using the Approval form. b) The use of the BIOLOGICAL RESOURCE is limited to academic research purposes only. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE containing Venus, an acknowledgment to Dr. Atsushi Miyawaki and a citation of the following literature(s) designated by the DEPOSITOR are requested. Nat. Biotechnol., 20, 87-90 (2002). |
Depositor | Takashi Hiiragi (Max Planck Institute for Moleucular Biomedicine) |
Strain Status | ![]() |
Strain Availability | ![]() |
Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
---|
No Data |